Literature DB >> 27890342

Impact of laparoscopic Roux-en-Y Gastric bypass versus sleeve gastrectomy on postoperative lipid values.

Andrew D Van Osdol1, Brandon T Grover2, Andrew J Borgert3, Kara J Kallies3, Shanu N Kothari4.   

Abstract

BACKGROUND: Metabolic surgery has been shown to significantly improve many obesity-related co-morbidities, including dyslipidemia. The literature has produced mixed results comparing postoperative lipid values after laparoscopic Roux-en-Y gastric bypass (LRYGB) compared to laparoscopic sleeve gastrectomy (LSG); with some indicating significantly greater reductions in total cholesterol and low-density lipoprotein (LDL) in LRYGB versus LSG, and others reporting no significant differences.
OBJECTIVES: To evaluate the postoperative lipid values after LRYGB versus LSG at a community hospital.
SETTING: Integrated multispecialty health system with a community teaching hospital.
METHODS: A retrospective review of our prospective database was completed to identify patients who underwent either LRYGB or LSG at our institution from 2001 through 2013. Lipid values available at 6-18 months postoperative were evaluated. Statistical analysis included χ2 and Wilcoxon rank-sum tests. A P value<.05 was considered significant.
RESULTS: There were 1326 and 121 patients who underwent LRYGB and LSG during the study period, respectively. Of these patients, 644 LRYGB and 67 LSG patients had pre- and postoperative lipid values available and included in the final analysis. Postoperative mean total cholesterol and LDL values were significantly lower in LYRGB versus LSG patients. Postoperatively, 10% and 30% of LRYGB and LSG patients had a total cholesterol values≥200 mg/dL (P<.001); 4% and 24% had LDL values≥130 mg/dL (P<.001); and 8% and 9% had triglyceride levels>130 mg/dL (P = .68), respectively. HDL values were within the recommended range in 52% and 57% of LRYGB and LSG patients, respectively (P = .64).
CONCLUSION: Patients who underwent LRYGB had a greater postoperative reduction in total cholesterol, LDL, and triglycerides. LRYGB may be the more appropriate bariatric procedure for patients with significant preoperative hypercholesterolemia.
Copyright © 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Cholesterol; Dyslipidemia; Lipids; Metabolic surgery; Postoperative outcomes; Roux-en-Y gastric bypass; Sleeve gastrectomy

Mesh:

Substances:

Year:  2016        PMID: 27890342     DOI: 10.1016/j.soard.2016.09.031

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  4 in total

1.  Laparoscopic Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Type 2 Diabetes Mellitus in Nonseverely Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yanhua Sha; Xianzhang Huang; Peifeng Ke; Bailin Wang; Hui Yuan; Wei Yuan; Yongliang Wang; Xuanjin Zhu; Yong Yan
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

2.  Effect of Laparoscopic Sleeve Gastrectomy on Static and Dynamic Measures of Glucose Homeostasis and Incretin Hormone Response 4-Years Post-Operatively.

Authors:  Thinzar Min; Sarah L Prior; Rachel Churm; Gareth Dunseath; Jonathan D Barry; Jeffrey W Stephens
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

3.  Lipoprotein(a) Change After Sleeve Gastrectomy Is Affected by the Presence of Metabolic Syndrome.

Authors:  Silvia Paredes; Marta Alves; Maria Lopes Pereira; Olinda Marques; Laura Ribeiro
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

4.  Temporal Effects of Bariatric Surgery on Adipokines, Inflammation and Oxidative Stress in Subjects with Impaired Glucose Homeostasis at 4 Years of Follow-up.

Authors:  Thinzar Min; Sarah L Prior; Gareth Dunseath; Rachel Churm; Jonathan D Barry; Jeffrey W Stephens
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.